PanopticAI, a Hong Kong-based health tech startup, has raised undisclosed seed funding from a round co-led by Alibaba Hong Kong Entrepreneurs Fund and Gobi Partners. The round was also participated by HKUST Entrepreneurship Fund and other investors.
Founded by researchers and scientists from The Hong Kong University of Science and Technology, PanopticAI is innovating next-generation digital health solutions to provide users with a holistic analysis of their health.
Its flagship product, Vitals, is a low-cost and hardware-agnostic contactless vitals measurement application. It captures via camera the subtle changes in the color of a user's skin, which is then processed through AI and signal processing to come up with comprehensive and accurate vital signs reading within 30 seconds. Vitals has been applied in various industries, including telemedicine, corporate wellness, construction, insurance, fitness, and mental health.
Vitals is useful to the lower income brackets and other vulnerable population segments across the globe as it provides affordable and quality healthcare services that can be easily accessed through our everyday devices.
Based on a press statement, PanopticAI will use its seed funding to accelerate its acquisition of regulatory approvals and further cement its presence across China's Greater Bay Area and other emerging markets. Currently, it has tie-ups with Gleneagles Hospital Hong Kong for remote health monitoring and local beauty retailer Mannings for smart health consultation services.
It is also looking to explore partnerships with global insurance firms to offer new solutions for straight-through processing, dynamic underwriting, and enhancing customer experience.
Join the HealthXL Meeting on ‘Digital Biomarkers for Mental Health Evaluation and Management’ on 16th February. Click here to Request to Join.
Click here to read the original news story.